The FDA just approved FAYUVI, the first-ever treatment for Sanfilippo syndrome type A: a one-time gene therapy from Ultragenyx priced at $3.95 million per patient.
AMD is paying $8.2 billion in stock for Fei-Fei Li's World Labs — a ~40-person, two-year-old startup — to buy its way into spatial AI and take a swing at Nvidia.
Hubble Network raised $200M at a $1.6B valuation to connect standard, sub-50-cent Bluetooth chips directly to satellites — no SIM, no tower, no new radio.
Island just raised a $400M Series F at a $6.4B valuation for its enterprise browser — as AI agents turn the humble tab into the place companies police their software.
Anthropic will pay Akamai $11.6 billion over seven years — potentially $20 billion — for CPU cloud capacity to run Claude, and handed over a warrant for up to 5% of the company.
DeepSeek went out for about $7 billion and investors came back with at least $12 billion, in a Tencent- and CATL-led round ahead of a planned 2027 IPO.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Bending Spoons is buying Airtable for $1.285 billion in all cash — about 89% below the productivity startup's $11.7B pandemic-era peak, and its first deal since going public.
The FDA just approved FAYUVI, the first-ever treatment for Sanfilippo syndrome type A: a one-time gene therapy from Ultragenyx priced at $3.95 million per patient.
Adicet's off-the-shelf CAR-T put 54% of a small lupus trial into remission on a single dose. Then the stock dropped 22%.
Precision Neuroscience closed an oversubscribed $250M Series D at a ~$1B valuation, betting its surface brain implant beats drilling into tissue.
